
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
Puhalla, Shannon, Sharon, Wilks, Brufsky, Adam, O'Shaughnessy, Joyce, Schwartzberg, Lee, Berrak, Erhan, Song, James, Vahdat, LindaVolume:
Volume 8
Langue:
english
Journal:
Breast Cancer: Targets and Therapy
DOI:
10.2147/BCTT.S98696
Date:
December, 2016
Fichier:
PDF, 464 KB
english, 2016